No benefit to community-wide dementia screening: review

by Mary Brophy Marcus, Healthday Reporter
No benefit to community-wide dementia screening: review
But worrisome symptoms could merit a visit to the doctor, experts say.

(HealthDay)—There's no proof that community-wide screening for dementia results in any emotional, clinical or economic benefits, new research indicates.

"We found no evidence that population screening would lead to better clinical or psychosocial outcomes, no evidence furthering our understanding of the risks it entails and no indication of its added value compared to current practice," said study author Carol Brayne, a professor of public health medicine from Cambridge Institute of Public Health, in the United Kingdom. She and her colleagues were to present their findings Wednesday at the annual Alzheimer's Association International Conference, in Boston.

For years, there has been wide debate among health advocacy groups and policymakers over whether or not community-wide screening for dementia helps patients and saves dollars. Because there is no cure for Alzheimer's, many argue against the need for it, but as many as 50 percent of people with dementia go undiagnosed, the authors said.

Given the debate, Brayne said she was surprised by "the extent of the lack of evidence that supports it [community-wide screening]."

For the study, she and colleagues reviewed all of the available studies on the issue. "We wanted to try to find all the relevant studies and then assess how well they addressed the specific question we were asking about screening in populations," said Brayne.

"Out of all of them, there were only six presenting some information about cost and ; we found none with regards to clinical and psychosocial outcomes, such as cognitive, , social and planning benefits of population screening," Brayne said.

The team added that significant resources are required to screen for , and there is no indication that it adds value compared to current .

Dr. Murali Doraiswamy, a professor of psychiatry and medicine at Duke University Medical Center and the author of The Alzheimer's Action Plan, said, "I think this study is empowering information in some sense. The general policy is we don't want to do screening unless two criteria are met: the screening test has to have a high degree of accuracy; and two, the results of the screening end up with some kind of an intervention that improves the outcome for a person."

For the vast number of screening tests, the value is overstressed, said Doraiswamy. "We're starting to learn as a country the massive harm people suffer as a result of promoting screening tests—from raising anxiety of patients to doing unnecessary procedures that result in incidental findings," he added.

The study results don't suggest ignoring troubling symptoms, though.

Family and friends worried about a loved one should check in with their doctor, said Dr. Heather Snyder, director of medical and scientific operations at the Alzheimer's Association. People who have a parent or sibling with Alzheimer's are at a higher risk, too, she said.

"If you are concerned about yourself or your loved one's ability to remember things, know the warnings signs of Alzheimer's, speak to your health care provider, or go to www.alz.org if you need help getting connected with a local physician," said Snyder.

She also pointed out that sometimes other health issues—such as hormone imbalances, multiple medication use and nutrition deficiencies—can cause memory problems, and they are treatable. "That's why it is important to speak to a health care provider if you have questions about memory changes," said Snyder.

Brayne said future research might focus on higher-risk groups. "A research program that tested systematic screening in populations that are known to be at higher risk could be part of a clearer strategy to generate the evidence we need to make informed decisions as a whole society," she noted.

Research presented at meetings should be viewed as preliminary until published in a peer-reviewed journal.

More information: For more on Alzheimer's, go to the U.S. Department of Health and Human Services.

add to favorites email to friend print save as pdf

Related Stories

Men say they want prostate cancer test, despite risks

Jul 09, 2013

A survey of men age 40 to 74 found that 54 percent said that they would still opt for a popular prostate cancer screening test despite recent recommendations that the test not be performed, finds a new study ...

Telephone intervention ups colorectal cancer screening

Jul 16, 2013

(HealthDay)—A telephone outreach intervention delivered by Medicaid managed care organization (MMCO) staff can increase rates of colorectal cancer (CRC) screening among women overdue for screening, according ...

Glaucoma screening not for everyone, experts say

Jul 09, 2013

(HealthDay)—Not enough evidence exists to recommend that primary-care doctors screen for glaucoma in adults who do not have vision problems, according to the U.S. Preventive Services Task Force.

Recommended for you

Can poor sleep lead to dementia?

Dec 10, 2014

People who have sleep apnea or spend less time in deep sleep may be more likely to have changes in the brain that are associated with dementia, according to a new study published in the December 10, 2014, ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.